IOL Chemicals and Pharmaceuticals vs Peers
- Market cap
- ₹5,996 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹147.07 – ₹275.76
IOL Chemicals and Pharmaceuticals ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are IOL Chemicals and Pharmaceuticals. Its P/E of 22.5 compares with a peer median of 22.5.
IOL Chemicals and Pharmaceuticals vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| IOL Chemicals and Pharmaceuticals | 204.27 | -0.62% | 5,996 | 22.5 | 2.85 | 14.5% | +18.5% |
| IOL Chemicals and Pharmaceuticals | 204.27 | -0.62% | 5,996 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
IOL Chemicals and Pharmaceuticals peer comparison — frequently asked questions
Who are IOL Chemicals and Pharmaceuticals' competitors?
IOL Chemicals and Pharmaceuticals' listed peers in Drug Manufacturers - Specialty & Generic include IOL Chemicals and Pharmaceuticals, ranked here by market capitalisation.
How does IOL Chemicals and Pharmaceuticals' P/E compare with its peers?
IOL Chemicals and Pharmaceuticals trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among IOL Chemicals and Pharmaceuticals' peers?
By market capitalisation, the largest company in the group is IOL Chemicals and Pharmaceuticals at ₹5,996 crore, against ₹5,996 crore for IOL Chemicals and Pharmaceuticals.
Same Data For Peers
Trade IOL Chemicals and Pharmaceuticals With ATS
Track IOLCP live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.